Contact: Suraj Waghmare; Last date for abstract submission: Not available; Having completed two extremely successful editions, MarketsandMarkets'is coming up with "3rd Annual Next-Gen Immuno-Oncology Congress" to discuss the latest updates in development of ADC"s, Bispecific Antibodies, Immune Checkpoint Inhibitors